Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $2.62 | $2.61 | -0.38% | 0.9M |
| 05-18 | $2.61 | $2.54 | -2.68% | 1.1M |
| 05-19 | $2.51 | $2.50 | -0.40% | 0.6M |
| 05-20 | $2.50 | $2.58 | +3.20% | 0.5M |
| 05-21 | $2.57 | $2.62 | +1.95% | 0.5M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $50.24M | $215.94M | $166.32M | $99.58M |
Operating Income | $5.04M | $31.36M | $26.85M | $11.32M |
Net Income | $2.92M | $32.44M | $30.01M | $19.79M |
EPS (Diluted) | $0.02 | $0.27 | $0.26 | $0.18 |
Total Assets | $400.88M | $423.10M | $418.38M | $403.74M |
Total Liabilities | $97.10M | $113.03M | $113.02M | $109.55M |
Cash & Equivalents | $50.47M | $81.19M | $82.56M | $59.99M |
Free Cash Flow OCF − CapEx | $-25.99M | $39.89M | $39.59M | $16.98M |
Shares Outstanding | 114.05M | 115.72M | 114.97M | 112.64M |